SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-058797
Filing Date
2024-03-05
Accepted
2024-03-05 09:01:27
Documents
1
Group Members
ANDREW M. WEISS PH.D.BIP GP LLCWAM GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d781829dsc13da.htm SC 13D/A 35982
  Complete submission text file 0001193125-24-058797.txt   37769
Mailing Address 222 BERKELEY STREET, 16TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET, 16TH FLOOR BOSTON MA 02116 617-778-7780
Weiss Asset Management LP (Filed by) CIK: 0001357550 (see all company filings)

IRS No.: 611451623 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88552 | Film No.: 24718443
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)